Target intelligence / Profile preview

Eukaryotic translation initiation factor 2 subunit 1 (eIF2α)

Target
eIF2α
Molecular classification
Translation initiation factor, Protein substrate, Signaling intermediary, Regulator of protein synthesis
01

Overview

Eukaryotic translation initiation factor 2 subunit 1 (eIF2α, encoded by EIF2S1) is a component of the eIF2 complex that mediates the binding of initiator methionyl-tRNA to the ribosome in a GTP-dependent manner, a critical step in the initiation of eukaryotic protein synthesis[1][10]. Phosphorylation of eIF2α on serine 51 by one of four specialized kinases (PERK, GCN2, PKR, HRI) in response to diverse cellular stresses is a central regulatory mechanism of the integrated stress response, producing global translational repression while permitting selective translation of stress-protective mRNAs such as ATF4[4][6]. Persistent or dysregulated eIF2α phosphorylation has been implicated in a range of diseases including cancer, neurodegeneration, infectious diseases, and anemia[4][6]. The pathway is an important target of pharmacological intervention, generally through modulation of eIF2α kinases or regulatory phosphatases, rather than direct targeting of eIF2α itself.

Other names
eIF2αEIF2S1Eukaryotic initiation factor 2 alphaTranslation initiation factor eIF-2 subunit 1IF2A
02

Mechanism of action

Inhibition or activation of eIF2α kinases (PERK, PKR, GCN2, HRI) to modulate phosphorylation state of eIF2α; Inhibition of eIF2α dephosphorylation (e.g., via GADD34 modulators); Indirect modulation (e.g., ISRIB stabilizes eIF2B and restores translation in the presence of eIF2α phosphorylation)

03

Biological functions

Regulation of translation initiationSignal transduction (as part of the integrated stress response)Control of cell fate under stress (cell cycle arrest, apoptosis induction, adaptation)
04

Disease associations

CancerNeurodegenerative diseasesInfectionMetabolic disordersInflammationAnemias and conditions of heme deficiency
05

Safety considerations

Global inhibition of translation via eIF2α phosphorylation can induce cell death or dysfunction in healthy tissuesExcessive or prolonged ISR activation may contribute to neurodegeneration, impaired memory, pancreatic dysfunction, and cancer therapy resistance
06

Interacting drugs

Integrated stress response inhibitor (ISRIB)

3 more in the full profile.

07

Biomarkers

Phosphorylated eIF2α (p-eIF2α)Downstream effectors such as ATF4 induction

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 2 subunit 1 (eIF2α).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 2 subunit 1 (eIF2α).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call